Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-09-10
Pages: 104 Pages
Report ld: 5034090
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Diabetes Testing Program Market Size(US$)
CAGR 2025-2031
7.5%
Market Size,2031
USD 4,134
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,674 million
Market Forecast in 2031(Value)
US$ 4,134 million
CAGR
7.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Diabetes Testing Program market size was US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
The Global key players of Diabetes Testing Program include Roche, LifeScan, Abbott Laboratories, etc. The top three players hold a share over 44%. China is the largest market, and has a share about 33%. In terms of product type, HbA1c Test is the largest segment, which occupied for a share of about 66%. For application, Home Test is the largest segment, which has a share about 42%.
The global Diabetes Testing Program market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Roche
- LifeScan
- Abbott Laboratories
- Ascensia
- Arkray
- I-SENS
- Omron
- Braun
- Siemens
- Bio-Rad Laboratories
- Tosoh
- Danaher Corporation
- Trinity Biotech
- HUMAN Diagnostics
- Terumo
- Sinocare
- Acon Biotech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- HbA1c Test
- Finger-prick Test
Segment by Application
- Medical Diagnosis
- Home Test
- Lab Testing
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Diabetes Testing Program market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Finger-prick Test in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Home Test in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Diabetes Testing Program value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 HbA1c Test
1.2.3 Finger-prick Test
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Diagnosis
1.3.3 Home Test
1.3.4 Lab Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Testing Program Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Diabetes Testing Program Revenue Market Share by Region (2020-2025)
2.4 Global Diabetes Testing Program Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Diabetes Testing Program Market Size and Prospective (2020-2031)
2.5.2 Europe Diabetes Testing Program Market Size and Prospective (2020-2031)
2.5.3 China Diabetes Testing Program Market Size and Prospective (2020-2031)
2.5.4 Japan Diabetes Testing Program Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Diabetes Testing Program Historic Market Size by Type (2020-2025)
3.2 Global Diabetes Testing Program Forecasted Market Size by Type (2026-2031)
3.3 Different Types Diabetes Testing Program Representative Players
4 Breakdown Data by Application
4.1 Global Diabetes Testing Program Historic Market Size by Application (2020-2025)
4.2 Global Diabetes Testing Program Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Diabetes Testing Program Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Diabetes Testing Program Players by Revenue (2020-2025)
5.1.2 Global Diabetes Testing Program Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Diabetes Testing Program Revenue
5.4 Global Diabetes Testing Program Market Concentration Analysis
5.4.1 Global Diabetes Testing Program Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Diabetes Testing Program Revenue in 2024
5.5 Global Key Players of Diabetes Testing Program Head office and Area Served
5.6 Global Key Players of Diabetes Testing Program, Product and Application
5.7 Global Key Players of Diabetes Testing Program, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Diabetes Testing Program Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Diabetes Testing Program Market Size by Type (2020-2025)
6.1.2.2 North America Diabetes Testing Program Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Diabetes Testing Program Market Size by Application (2020-2025)
6.1.3.2 North America Diabetes Testing Program Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Diabetes Testing Program Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Diabetes Testing Program Market Size by Type (2020-2025)
6.2.2.2 Europe Diabetes Testing Program Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Diabetes Testing Program Market Size by Application (2020-2025)
6.2.3.2 Europe Diabetes Testing Program Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Diabetes Testing Program Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Diabetes Testing Program Market Size by Type (2020-2025)
6.3.2.2 China Diabetes Testing Program Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Diabetes Testing Program Market Size by Application (2020-2025)
6.3.3.2 China Diabetes Testing Program Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Diabetes Testing Program Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Diabetes Testing Program Market Size by Type (2020-2025)
6.4.2.2 Japan Diabetes Testing Program Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Diabetes Testing Program Market Size by Application (2020-2025)
6.4.3.2 Japan Diabetes Testing Program Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Roche
7.1.1 Roche Company Details
7.1.2 Roche Business Overview
7.1.3 Roche Diabetes Testing Program Introduction
7.1.4 Roche Revenue in Diabetes Testing Program Business (2020-2025)
7.1.5 Roche Recent Development
7.2 LifeScan
7.2.1 LifeScan Company Details
7.2.2 LifeScan Business Overview
7.2.3 LifeScan Diabetes Testing Program Introduction
7.2.4 LifeScan Revenue in Diabetes Testing Program Business (2020-2025)
7.2.5 LifeScan Recent Development
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Company Details
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories Diabetes Testing Program Introduction
7.3.4 Abbott Laboratories Revenue in Diabetes Testing Program Business (2020-2025)
7.3.5 Abbott Laboratories Recent Development
7.4 Ascensia
7.4.1 Ascensia Company Details
7.4.2 Ascensia Business Overview
7.4.3 Ascensia Diabetes Testing Program Introduction
7.4.4 Ascensia Revenue in Diabetes Testing Program Business (2020-2025)
7.4.5 Ascensia Recent Development
7.5 Arkray
7.5.1 Arkray Company Details
7.5.2 Arkray Business Overview
7.5.3 Arkray Diabetes Testing Program Introduction
7.5.4 Arkray Revenue in Diabetes Testing Program Business (2020-2025)
7.5.5 Arkray Recent Development
7.6 I-SENS
7.6.1 I-SENS Company Details
7.6.2 I-SENS Business Overview
7.6.3 I-SENS Diabetes Testing Program Introduction
7.6.4 I-SENS Revenue in Diabetes Testing Program Business (2020-2025)
7.6.5 I-SENS Recent Development
7.7 Omron
7.7.1 Omron Company Details
7.7.2 Omron Business Overview
7.7.3 Omron Diabetes Testing Program Introduction
7.7.4 Omron Revenue in Diabetes Testing Program Business (2020-2025)
7.7.5 Omron Recent Development
7.8 Braun
7.8.1 Braun Company Details
7.8.2 Braun Business Overview
7.8.3 Braun Diabetes Testing Program Introduction
7.8.4 Braun Revenue in Diabetes Testing Program Business (2020-2025)
7.8.5 Braun Recent Development
7.9 Siemens
7.9.1 Siemens Company Details
7.9.2 Siemens Business Overview
7.9.3 Siemens Diabetes Testing Program Introduction
7.9.4 Siemens Revenue in Diabetes Testing Program Business (2020-2025)
7.9.5 Siemens Recent Development
7.10 Bio-Rad Laboratories
7.10.1 Bio-Rad Laboratories Company Details
7.10.2 Bio-Rad Laboratories Business Overview
7.10.3 Bio-Rad Laboratories Diabetes Testing Program Introduction
7.10.4 Bio-Rad Laboratories Revenue in Diabetes Testing Program Business (2020-2025)
7.10.5 Bio-Rad Laboratories Recent Development
7.11 Tosoh
7.11.1 Tosoh Company Details
7.11.2 Tosoh Business Overview
7.11.3 Tosoh Diabetes Testing Program Introduction
7.11.4 Tosoh Revenue in Diabetes Testing Program Business (2020-2025)
7.11.5 Tosoh Recent Development
7.12 Danaher Corporation
7.12.1 Danaher Corporation Company Details
7.12.2 Danaher Corporation Business Overview
7.12.3 Danaher Corporation Diabetes Testing Program Introduction
7.12.4 Danaher Corporation Revenue in Diabetes Testing Program Business (2020-2025)
7.12.5 Danaher Corporation Recent Development
7.13 Trinity Biotech
7.13.1 Trinity Biotech Company Details
7.13.2 Trinity Biotech Business Overview
7.13.3 Trinity Biotech Diabetes Testing Program Introduction
7.13.4 Trinity Biotech Revenue in Diabetes Testing Program Business (2020-2025)
7.13.5 Trinity Biotech Recent Development
7.14 HUMAN Diagnostics
7.14.1 HUMAN Diagnostics Company Details
7.14.2 HUMAN Diagnostics Business Overview
7.14.3 HUMAN Diagnostics Diabetes Testing Program Introduction
7.14.4 HUMAN Diagnostics Revenue in Diabetes Testing Program Business (2020-2025)
7.14.5 HUMAN Diagnostics Recent Development
7.15 Terumo
7.15.1 Terumo Company Details
7.15.2 Terumo Business Overview
7.15.3 Terumo Diabetes Testing Program Introduction
7.15.4 Terumo Revenue in Diabetes Testing Program Business (2020-2025)
7.15.5 Terumo Recent Development
7.16 Sinocare
7.16.1 Sinocare Company Details
7.16.2 Sinocare Business Overview
7.16.3 Sinocare Diabetes Testing Program Introduction
7.16.4 Sinocare Revenue in Diabetes Testing Program Business (2020-2025)
7.16.5 Sinocare Recent Development
7.17 Acon Biotech
7.17.1 Acon Biotech Company Details
7.17.2 Acon Biotech Business Overview
7.17.3 Acon Biotech Diabetes Testing Program Introduction
7.17.4 Acon Biotech Revenue in Diabetes Testing Program Business (2020-2025)
7.17.5 Acon Biotech Recent Development
8 Diabetes Testing Program Market Dynamics
8.1 Diabetes Testing Program Industry Trends
8.2 Diabetes Testing Program Market Drivers
8.3 Diabetes Testing Program Market Challenges
8.4 Diabetes Testing Program Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Diabetes Testing Program Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Diabetes Testing Program Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Diabetes Testing Program Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Diabetes Testing Program Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Diabetes Testing Program Revenue Share by Region (2020-2025)
Table 6. Global Diabetes Testing Program Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Diabetes Testing Program Revenue Share Forecast by Region (2026-2031)
Table 8. Global Diabetes Testing Program Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Diabetes Testing Program Revenue Market Share by Type (2020-2025)
Table 10. Global Diabetes Testing Program Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Diabetes Testing Program Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Diabetes Testing Program Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Diabetes Testing Program Revenue Market Share by Application (2020-2025)
Table 15. Global Diabetes Testing Program Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Diabetes Testing Program Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Diabetes Testing Program Application
Table 18. Global Diabetes Testing Program Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Diabetes Testing Program Market Share by Players (2020-2025)
Table 20. Global Top Diabetes Testing Program Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Testing Program as of 2024)
Table 21. Ranking of Global Top Diabetes Testing Program Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Diabetes Testing Program Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Diabetes Testing Program, Headquarters and Area Served
Table 24. Global Key Players of Diabetes Testing Program, Product and Application
Table 25. Global Key Players of Diabetes Testing Program, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Diabetes Testing Program Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Diabetes Testing Program Revenue Market Share by Company (2020-2025)
Table 29. North America Diabetes Testing Program Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Diabetes Testing Program Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Diabetes Testing Program Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Diabetes Testing Program Revenue Market Share by Company (2020-2025)
Table 33. Europe Diabetes Testing Program Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Diabetes Testing Program Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Diabetes Testing Program Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Diabetes Testing Program Revenue Market Share by Company (2020-2025)
Table 37. China Diabetes Testing Program Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Diabetes Testing Program Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Diabetes Testing Program Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Diabetes Testing Program Revenue Market Share by Company (2020-2025)
Table 41. Japan Diabetes Testing Program Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Diabetes Testing Program Market Size by Application (2020-2025) & (US$ Million)
Table 43. Roche Company Details
Table 44. Roche Business Overview
Table 45. Roche Diabetes Testing Program Product
Table 46. Roche Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 47. Roche Recent Development
Table 48. LifeScan Company Details
Table 49. LifeScan Business Overview
Table 50. LifeScan Diabetes Testing Program Product
Table 51. LifeScan Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 52. LifeScan Recent Development
Table 53. Abbott Laboratories Company Details
Table 54. Abbott Laboratories Business Overview
Table 55. Abbott Laboratories Diabetes Testing Program Product
Table 56. Abbott Laboratories Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 57. Abbott Laboratories Recent Development
Table 58. Ascensia Company Details
Table 59. Ascensia Business Overview
Table 60. Ascensia Diabetes Testing Program Product
Table 61. Ascensia Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 62. Ascensia Recent Development
Table 63. Arkray Company Details
Table 64. Arkray Business Overview
Table 65. Arkray Diabetes Testing Program Product
Table 66. Arkray Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 67. Arkray Recent Development
Table 68. I-SENS Company Details
Table 69. I-SENS Business Overview
Table 70. I-SENS Diabetes Testing Program Product
Table 71. I-SENS Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 72. I-SENS Recent Development
Table 73. Omron Company Details
Table 74. Omron Business Overview
Table 75. Omron Diabetes Testing Program Product
Table 76. Omron Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 77. Omron Recent Development
Table 78. Braun Company Details
Table 79. Braun Business Overview
Table 80. Braun Diabetes Testing Program Product
Table 81. Braun Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 82. Braun Recent Development
Table 83. Siemens Company Details
Table 84. Siemens Business Overview
Table 85. Siemens Diabetes Testing Program Product
Table 86. Siemens Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 87. Siemens Recent Development
Table 88. Bio-Rad Laboratories Company Details
Table 89. Bio-Rad Laboratories Business Overview
Table 90. Bio-Rad Laboratories Diabetes Testing Program Product
Table 91. Bio-Rad Laboratories Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 92. Bio-Rad Laboratories Recent Development
Table 93. Tosoh Company Details
Table 94. Tosoh Business Overview
Table 95. Tosoh Diabetes Testing Program Product
Table 96. Tosoh Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 97. Tosoh Recent Development
Table 98. Danaher Corporation Company Details
Table 99. Danaher Corporation Business Overview
Table 100. Danaher Corporation Diabetes Testing Program Product
Table 101. Danaher Corporation Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 102. Danaher Corporation Recent Development
Table 103. Trinity Biotech Company Details
Table 104. Trinity Biotech Business Overview
Table 105. Trinity Biotech Diabetes Testing Program Product
Table 106. Trinity Biotech Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 107. Trinity Biotech Recent Development
Table 108. HUMAN Diagnostics Company Details
Table 109. HUMAN Diagnostics Business Overview
Table 110. HUMAN Diagnostics Diabetes Testing Program Product
Table 111. HUMAN Diagnostics Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 112. HUMAN Diagnostics Recent Development
Table 113. Terumo Company Details
Table 114. Terumo Business Overview
Table 115. Terumo Diabetes Testing Program Product
Table 116. Terumo Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 117. Terumo Recent Development
Table 118. Sinocare Company Details
Table 119. Sinocare Business Overview
Table 120. Sinocare Diabetes Testing Program Product
Table 121. Sinocare Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 122. Sinocare Recent Development
Table 123. Acon Biotech Company Details
Table 124. Acon Biotech Business Overview
Table 125. Acon Biotech Diabetes Testing Program Product
Table 126. Acon Biotech Revenue in Diabetes Testing Program Business (2020-2025) & (US$ Million)
Table 127. Acon Biotech Recent Development
Table 128. Diabetes Testing Program Market Trends
Table 129. Diabetes Testing Program Market Drivers
Table 130. Diabetes Testing Program Market Challenges
Table 131. Diabetes Testing Program Market Restraints
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Diabetes Testing Program Product Picture
Figure 2. Global Diabetes Testing Program Market Share by Type: 2024 VS 2031
Figure 3. HbA1c Test Features
Figure 4. Finger-prick Test Features
Figure 5. Global Diabetes Testing Program Market Share by Application: 2024 VS 2031
Figure 6. Medical Diagnosis
Figure 7. Home Test
Figure 8. Lab Testing
Figure 9. Diabetes Testing Program Report Years Considered
Figure 10. Global Diabetes Testing Program Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Diabetes Testing Program Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Diabetes Testing Program Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Diabetes Testing Program Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Diabetes Testing Program Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Diabetes Testing Program Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Diabetes Testing Program Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Global Diabetes Testing Program Market Share by Players in 2024
Figure 18. Global Top Diabetes Testing Program Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Testing Program as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Diabetes Testing Program Revenue in 2024
Figure 20. North America Diabetes Testing Program Market Share by Type (2020-2025)
Figure 21. North America Diabetes Testing Program Market Share by Application (2020-2025)
Figure 22. Europe Diabetes Testing Program Market Share by Type (2020-2025)
Figure 23. Europe Diabetes Testing Program Market Share by Application (2020-2025)
Figure 24. China Diabetes Testing Program Market Share by Type (2020-2025)
Figure 25. China Diabetes Testing Program Market Share by Application (2020-2025)
Figure 26. Japan Diabetes Testing Program Market Share by Type (2020-2025)
Figure 27. Japan Diabetes Testing Program Market Share by Application (2020-2025)
Figure 28. Roche Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 29. LifeScan Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 30. Abbott Laboratories Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 31. Ascensia Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 32. Arkray Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 33. I-SENS Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 34. Omron Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 35. Braun Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 36. Siemens Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 37. Bio-Rad Laboratories Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 38. Tosoh Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 39. Danaher Corporation Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 40. Trinity Biotech Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 41. HUMAN Diagnostics Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 42. Terumo Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 43. Sinocare Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 44. Acon Biotech Revenue Growth Rate in Diabetes Testing Program Business (2020-2025)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Diabetes Testing Program market?
The top companies in the global Diabetes Testing Program market are Roche、LifeScan、Abbott Laboratories.
Which region is expected to have the highest market share?
What was the global market size of Diabetes Testing Program in 2031?
What was the global market size of Diabetes Testing Program in 2025?
What is the annual compound growth rate of the global Diabetes Testing Program market size from 2025 to 2031?
Related Reports
Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Diabetes Testing Program market size was US$ 2674 million in 2025 and is forecast to reach a readjusted size of US$ 4414 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 105
USD 4250.00
(Single User License)
Global Diabetes Testing Program Market Research Report 2026
The global Diabetes Testing Program market was valued at US$ 2674 million in 2025 and is anticipated to reach US$ 4414 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 126
USD 2900.00
(Single User License)
Diabetes Testing Program - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Testing Program was estimated to be worth US$ 2674 million in 2025 and is projected to reach US$ 4414 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 137
USD 3950.00
(Single User License)
Global Diabetes Testing Program Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diabetes Testing Program market is projected to grow from US$ 2504 million in 2024 to US$ 4134 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 152
USD 4900.00
(Single User License)
Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetes Testing Program was estimated to be worth US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 129
USD 3950.00
(Single User License)
Global Diabetes Testing Program Market Research Report 2025
The global market for Diabetes Testing Program was valued at US$ 2504 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-01-19
Pages: 92
USD 2900.00
(Single User License)
Global and United States Diabetes Testing Program Market Report & Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 122
USD 4350.00
(Single User License)
Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 125
USD 3950.00
(Single User License)
Global Diabetes Testing Program Market Research Report 2024
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 99
USD 2900.00
(Single User License)
Global Diabetes Testing Program Market Insights, Forecast to 2030
Published Date: 2024-03-20
Pages: 197
USD 4900.00
(Single User License)
Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Diabetes Testing Program market size was US$ 2674 million in 2025 and is forecast to reach a readjusted size of US$ 4414 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 105
USD 4250.00 (Single User License)Global Diabetes Testing Program Market Research Report 2026
The global Diabetes Testing Program market was valued at US$ 2674 million in 2025 and is anticipated to reach US$ 4414 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-05
Pages: 126
USD 2900.00 (Single User License)Diabetes Testing Program - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Testing Program was estimated to be worth US$ 2674 million in 2025 and is projected to reach US$ 4414 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-05
Pages: 137
USD 3950.00 (Single User License)Global Diabetes Testing Program Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diabetes Testing Program market is projected to grow from US$ 2504 million in 2024 to US$ 4134 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 152
USD 4900.00 (Single User License)Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetes Testing Program was estimated to be worth US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 129
USD 3950.00 (Single User License)Global Diabetes Testing Program Market Research Report 2025
The global market for Diabetes Testing Program was valued at US$ 2504 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-01-19
Pages: 92
USD 2900.00 (Single User License)Global and United States Diabetes Testing Program Market Report & Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 122
USD 4350.00 (Single User License)Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 125
USD 3950.00 (Single User License)Global Diabetes Testing Program Market Research Report 2024
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 99
USD 2900.00 (Single User License)Global Diabetes Testing Program Market Insights, Forecast to 2030
Published: 2024-03-20
Pages: 197
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now